Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Short telomeres: a novel potential predictor of relapse in Ewing sarcomaSmadar Avigad, Inna Naumov, Anat Ohali, et al.
International Journal of Clinical Oncology|June 19, 2021
Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemicMichal Dvori, Sarah Elitzur, Assaf Barg, et al.
Harefuah|May 29, 2017
[FERTILITY PRESERVATION IN YOUNG CANCER PATIENTS - CAN WE OPTIMIZE THE PATH?]Irit Ben-Aharon, Shifra Ash, Avi Ben-Haroush, et al.
Pediatric Blood & Cancer|July 27, 2025
Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms TumorAlissa Groisser, Amy Frantz, James I Geller, et al.
Cancers|August 26, 2022
Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study ResultsVassilios Papadakis, Vanessa Segura, Massimo Conte, et al.
Cancers|October 20, 2018
Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 TrialNikolai Siebert, Sascha Troschke-Meurer, Madlen Marx, et al.
Cancers|October 27, 2022
Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective StudyEldad Elnekave, Eytan Ben Ami, Sivan Shamai, et al.
The Israel Medical Association Journal : IMAJ|March 15, 2013
Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastomaMyriam Weyl Ben-Arush, Ayelet Ben Barak, Raquel Bar-Deroma, et al.
The American Journal of Pathology|April 17, 2010
2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristicsMarta Jeison, Shifra Ash, Gili Halevy-Berko, et al.
Pediatric Blood & Cancer|November 18, 2020
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group projectLucas Moreno, Dongjing Guo, Meredith S Irwin, et al.
Pageof 8